RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
1.390
+0.060 (4.52%)
At close: Aug 13, 2025, 4:00 PM
1.420
+0.030 (2.15%)
After-hours: Aug 13, 2025, 6:58 PM EDT
RedHill Biopharma Employees
RedHill Biopharma had 35 employees as of December 31, 2024. The number of employees decreased by 18 or -33.96% compared to the previous year.
Employees
35
Change (1Y)
-18
Growth (1Y)
-33.96%
Revenue / Employee
$229,800
Profits / Employee
-$236,229
Market Cap
3.19M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
RDHL News
- 23 days ago - RedHill Receives Positive FDA Feedback on Pathway to Approval of Groundbreaking RHB-204 for Crohn's Disease - PRNewsWire
- 6 weeks ago - RedHill Biopharma Announces Recruitment Initiated into Expanded Phase 2 Opaganib/Darolutamide Combination Study in Advanced Prostate Cancer - PRNewsWire
- 3 months ago - RedHill Biopharma Secures Kukbo Asset Freeze Following RedHill's $8.25 Million Plus Legal Fees New York Supreme Court Summary Judgment Win - PRNewsWire
- 3 months ago - RedHill-Supported Medscape H. Pylori Educational Program to Launch at Major Gastroenterology Congress - PRNewsWire
- 3 months ago - RedHill Biopharma Secures Allowance of Key Chinese Patent Application for Proprietary COVID-19 Treatment, RHB-107 - PRNewsWire
- 4 months ago - RedHill Biopharma Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency - PRNewsWire
- 4 months ago - RedHill Biopharma's Positive Opaganib Weight Loss & Diabetes Data Published: Signals Potential $100B Market Disruption - PRNewsWire
- 4 months ago - RedHill Biopharma Announces Full-Year 2024 Financial Results and Operational Highlights - PRNewsWire